Technological advancements in the healthcare industry coupled with the changing lifestyle and food habits of the major population are influencing the market growth.
Market Size – USD 33.99 Billion in 2018, Market Growth - CAGR of 4.7%, Market Trends – Demand for Allergy Diagnostics and Therapeutics in the healthcare industry.
The global Allergy Diagnostics and Therapeutics market is forecast to reach USD 49.57 Billion by 2026, according to a new report by Reports and Data. This is mainly contributed by the increase in the prevalence of allergies among the population. The technological advancements in the healthcare industry coupled with the changing lifestyle and food habits of the major population will drive the growth of the market. These allergic diseases can occur at almost any age, though some allergies are most likely to develop for the first time in particular age groups, especially in the geriatric population.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-allergy-diagnostics-and-therapeutics-market
Further key findings from the report suggest
- The market is segmented on the basis of product into instruments, consumables, and services.
- The consumables segment accounts for the largest market share of ~50% in the year 2018 and is forecasted to witness the highest growth rate of 5.5% during the forecast period. The advancements in the healthcare and pharmaceuticals industry to detect allergic diseases in patients is the factor driving the growth of the segment.
- For instance, assay kits are necessary and readily available consumables, used in life science research, drug discovery & development, and environmental monitoring.
- The in vivo test accounts for a larger market share of ~60% in the year 2018.
- In vivo tests are widely used by healthcare and research industries since they are able to simulate realistic and clinically relevant test environment and conditions.
- The market is segmented on the basis of drug class into antihistamines, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, decongestants, immunomodulators, autoinjectable epinephrine, and immunotherapy.
- The antihistamines drug class accounts for the largest market share of ~20% in the year 2018.
- Antihistamines are used to treat allergic diseases, especially rhinitis. It is an inexpensive, and generic drug that provides relief from nasal congestion, sneezing, or hives caused by pollen, dust mites, or animal allergy.
- The market is segmented on the basis of end users into academic research institutes, hospitals, and diagnostic laboratories.
- The diagnostic laboratories account for the largest market share of ~52% in the year 2018, owing to the growing prevalence of allergic diseases and the need for proper treatment and detection of those diseases.
For the purpose of this report, Reports and Data have segmented global Allergy Diagnostics and Therapeutics Market on the basis of product, allergen type, test type, drug class, end user, and region:
Products Outlook (Revenue, USD Billion; 2018-2026)
- Instruments
- Consumables
- Services
Allergen type Outlook (Revenue, USD Billion; 2018-2026)
- Food
- Inhaled
- Drug
Test type Outlook (Revenue, USD Billion; 2018-2026)
- In Vivo
- In Vitro
Drug class Outlook (Revenue, USD Billion; 2018-2026)
- Antihistamines
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anticholinergics
- Decongestants
- Immunomodulators
- Autoinjectable Epinephrine
- Immunotherapy
End users Outlook (Revenue, USD Billion; 2018-2026)
- Academic Research Institutes
- Hospitals
- Diagnostic Laboratories
Request
For Free PDF Sample Of This Research Report At: https://www.reportsanddata.com/sample-enquiry-form/1370
Regional Outlook (Revenue, USD Billion; 2018-2026)
- North America
- U.S.
- Europe
- France
- UK
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- MEA
No comments:
Post a Comment